StonvexLoading…
StonvexStonvexStonvexCore line items from INVX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $978.25M | $660.80M | $555.54M | $467.19M |
Operating Income | $132.63M | $49.08M | $97.28M | $75.84M |
Net Income | $83.30M | $140.32M | $73.93M | $63.28M |
EPS (Diluted) | $1.20 | $2.77 | $2.29 | $2.01 |
Total Assets | $1.27B | $1.20B | $475.30M | $969.95M |
Total Liabilities | $210.61M | $239.33M | $146.38M | $97.60M |
Cash & Equivalents | $203.41M | $73.28M | $187.32M | $259.41M |
Free Cash Flow OCF − CapEx | Not available | Not available | $43.24M | $-24.68M |
Shares Outstanding | 69.08M | 69.18M | 30.93M | 34.16M |